Ozone is a common urban environmental air pollutant and significantly contributes to hospitalizations for respiratory illness. The mechanisms, which regulate ozone-induced bronchoconstriction, remain poorly understood. Hyaluronan was recently shown to play a central role in the response to noninfectious lung injury. Therefore, we hypothesized that hyaluronan contributes to airway hyperreactivity (AHR) after exposure to ambient ozone. Using an established model of ozone-induced airways disease, we characterized the role of hyaluronan in airway hyperresponsiveness. The role of hyaluronan in response to ozone was determined by using therapeutic blockade, genetically modified animals, and direct challenge to hyaluronan. Ozone-exposed mice demonstrate enhanced AHR associated with elevated hyaluronan levels in the lavage fluid. Mice deficient in either CD44 (the major receptor for hyaluronan) or inter-␣-trypsin inhibitor (molecule that facilitates hyaluronan binding) show similar elevations in hyaluronan but are protected from ozone-induced AHR. Mice pretreated with hyaluronan-binding peptide are protected from the development of ozone-induced AHR. Overexpression of hyaluronan enhances the airway response to ozone. Intratracheal instillation of endotoxin-free low molecular weight hyaluronan induces AHR dependent on CD44, whereas instillation of high molecular weight hyaluronan protects against ozone-induced AHR. In conclusion, we demonstrate that hyaluronan mediates ozoneinduced AHR, which is dependent on the fragment size and both CD44 and inter-␣-trypsin inhibitor. These data support the conclusion that pulmonary matrix can contribute to the development of airway hyperresponsiveness.Ozone is a commonly encountered urban air pollutant that significantly contributes to increased morbidity (1-4) and can lead to a significant economic burden. It has been estimated that each year inhalation of ambient ozone contributes to 800 premature deaths, 4,500 hospital admissions, 900,000 school absences, and more than 1 million restricted activity days with an estimated $5 billion annual economic burden (5). Population-based studies suggest that for each 10 ppb increase in 1-h daily maximum level of ozone there is an increase in mortality risk of 0.39 -0.87%, especially in individuals with pre-existing respiratory disease (2, 3, 6, 7). However, the biological mechanisms, which regulate the response to ambient ozone exposure, remain poorly understood.Hyaluronan is an abundant extracellular matrix component, which has been recently shown to play a significant role in the response to noninfectious lung injury. Short fragment hyaluronan (sHA) 2 is released in the lung after sterile injury such as bleomycin instillation (8) or high tidal volume ventilation (9) and can modify the tissue response to injury. Furthermore, hyaluronan has been identified in airway secretions from asthmatics (10), and high molecular weight hyaluronan can attenuate the bronchoconstrictive response in exercise-induced asthma (11). We therefore hypothesized that...